| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/31/2009 | US7511128 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
| 03/31/2009 | US7511127 Compositions, methods and systems for inferring bovine breed |
| 03/31/2009 | US7511126 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
| 03/31/2009 | US7511123 Binding to antigen; controlling concentration |
| 03/31/2009 | US7511122 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions |
| 03/31/2009 | US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| 03/31/2009 | US7511027 Administering a nucleoside or a nucleoside analog, such as (5'-fluoro-5-methyl-beta-arabinofuranosyl-uridine) or salt or prodrug that suppresses the expression of hepatitis B surface or preS1 antigen in the host 100-fold |
| 03/31/2009 | US7511024 Factor VII or VIIA-like molecules |
| 03/31/2009 | US7511012 Myostatin binding agents |
| 03/31/2009 | US7510878 Bacillus thuringiensis gene with lepidopteran activity |
| 03/31/2009 | US7510875 Methods for producing purified adenoviral vectors |
| 03/31/2009 | US7510874 Stable cell lines expressing HERG1a and HERG1b |
| 03/31/2009 | US7510872 Transgenic cell comprising adenoviral vector for use as gene delivery tool; tissue engineering heterologous gene expression; DNA vaccines |
| 03/31/2009 | US7510870 STAT3 activated stem cell |
| 03/31/2009 | US7510869 A pSYCO109mcs plasmid comprising restriction endonuclease recognition sites useful for cloning at least three different genes or operons, each flanked by a terminator sequence and variants of glucose isomerase promoters for varying levels of protein expression |
| 03/31/2009 | US7510868 Chimeric adenoviruses for use in cancer treatment |
| 03/31/2009 | US7510867 Expression may be controlled by a regulatory element along with a small polyadenylation signal; entire gene expression cassettes may be packaged into a viral vector, preferably an adeno-associated virus vector; five or six rod repeats; cysteine-rich domain; muscular dystrophy |
| 03/31/2009 | US7510862 Nucleic acid comprising retroviral sequences for use as tools in generation of vaccines for prevention of viral diseases and infection; immunotherapy; viricides, antisense agents |
| 03/31/2009 | US7510861 Gluconate dehydratase |
| 03/31/2009 | US7510859 Shampoo, hair dye, hair bleach, denture care, anticaries agents, detergents, rinses, antiseptics; low temperature bleach boosters; controlled release bleach at milder pH |
| 03/31/2009 | US7510858 IRAK 1c splice variant and its use |
| 03/31/2009 | US7510856 Method for plasmid preparation by conversion of open circular plasmid to supercoiled plasmid |
| 03/31/2009 | US7510855 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 03/31/2009 | US7510854 Using transgenic gramnegative bacteria as biorecator for fermentation of methione and lysine for use in medicine, cosmetics and animal feeds |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | US7510852 Biosynthetic genes and host cells for the synthesis of polyketide antibiotics and method of use |
| 03/31/2009 | US7510851 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia |
| 03/31/2009 | US7510848 Enzyme resistance; chromatography; bovine spongiform encephalopathy; detecting and separating from whole blood sample, prion protein bound to binding material,wherein the polymeric prion protein binding material comprises an aminated, sulfonated, butylated, or arylated polymethacrylate matrix |
| 03/31/2009 | US7510847 Drug screening for compound having uricosuric regulating action by incubating a transformed cell expressing a recombinant protein with uric acid; and determining an uptake of uric acid; gout |
| 03/31/2009 | US7510843 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 03/31/2009 | US7510831 Expression vector comprising nucleotide sequences coding phytase for use in transformation and expression in aspergillus; enhancing nutrient quality of animal feeds |
| 03/31/2009 | US7510829 Primers for use in the amplification of preferential nucleotide sequences |
| 03/31/2009 | US7510826 Process for the depletion or removal of endotoxins |
| 03/31/2009 | US7510718 Expression vector comprising nucleotide sequences coding multimeric nuclear anchoring-protein for use as tool in transfer, expression and propagation of heterologous gene sequences |
| 03/31/2009 | US7510717 Non-toxic mutants of pathogenic gram-negative bacteria |
| 03/31/2009 | US7510711 Nucleotide sequence coding monoclonal antibody; anticancer agents; antiinflammatory agents; immunology disorders |
| 03/31/2009 | US7510706 Pseudotype retroviral vectors containing membrane proteins having hemagglutinin activity |
| 03/31/2009 | US7509880 Fluid flow meter body with high immunity to inlet/outlet flow disturbances |
| 03/31/2009 | CA2494888C Substances for preventing and treating autoimmune diseases |
| 03/31/2009 | CA2360543C Binary probe and clamp composition and methods for target hybridization detection |
| 03/31/2009 | CA2289961C A gene causative of rheumatoid arthritis, method for diagnosing rheumatoid arthritis, and method for identifying causative factors of rheumatoid arthritis |
| 03/31/2009 | CA2216126C Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 03/31/2009 | CA2192467C Calcium binding recombinant antibody against protein c |
| 03/31/2009 | CA2066204C Cystic fibrosis gene |
| 03/26/2009 | WO2009039517A1 Energy efficient and greenhouse gas efficient biofuel |
| 03/26/2009 | WO2009039507A2 Identification and isolation of fetal cells and nucleic acid |
| 03/26/2009 | WO2009039487A1 Chimeric cytochrome p450 proteins and methods of use |
| 03/26/2009 | WO2009039442A1 Nfia in glial fate determination, glioma therapy and astrocytoma treatment |
| 03/26/2009 | WO2009039414A2 Methods and compositions for detection of ehrlichia chaffeensis (vlpt) |
| 03/26/2009 | WO2009039300A2 Compositions comprising hif-1 alpha sirna and methods of use thereof |
| 03/26/2009 | WO2009039199A2 Compositions comprising stat5 sirna and methods of use thereof |
| 03/26/2009 | WO2009039189A2 Compositions comprising stat3 sirna and methods of use thereof |
| 03/26/2009 | WO2009039173A2 SiRNA SEQUENCE-INDEPENDENT MODIFICATION FORMATS FOR REDUCING OFF-TARGET PHENOTYPIC EFFECTS IN RNAi, AND STABILIZED FORMS THEREOF |
| 03/26/2009 | WO2009039001A1 Compositions and methods for the modification of physiological responses in plants |
| 03/26/2009 | WO2009038760A2 Human gm-csf antigen binding proteins |
| 03/26/2009 | WO2009038707A2 Cancer-testis gene silencing agents and uses thereof |
| 03/26/2009 | WO2009038581A2 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline and oxidative conditions |
| 03/26/2009 | WO2009038475A1 Systems for expression of heterologous proteins in m. capsulatus |
| 03/26/2009 | WO2009038462A1 Use of aav replication machinery for improved protein production |
| 03/26/2009 | WO2009038283A1 Vector for cell surface expression of pig igg fc domain, host cell transformed with the vector, and method of manufacturing vaccine against viruses related to pig diseases using the host cell |
| 03/26/2009 | WO2009038270A1 Respiratory syncytial virus vaccine |
| 03/26/2009 | WO2009038266A1 Method for enhancing serum stability and lowering immune response of sirna down-regulating gene expression of hbv or hcv |
| 03/26/2009 | WO2009038203A1 Temperature control method and system |
| 03/26/2009 | WO2009038195A1 Mutant pyrrolysyl-trna synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same |
| 03/26/2009 | WO2009038194A1 Recombinant microorganism and method for producing poly-gamma-glutamic acid |
| 03/26/2009 | WO2009037950A1 TRANSGENIC NON-HUMAN MAMMAL CAPABLE OF CONDITIONALLY EXPRESSING HUMAN K-ras MUTANT (K-rasV12) GENE, AND USE THEREOF |
| 03/26/2009 | WO2009037575A2 Multiplex pcr assay for identification of usa300 and usa400 community-associated methicillin resistant staphylococcal aureus strains |
| 03/26/2009 | WO2009037502A1 Modified xylan production |
| 03/26/2009 | WO2009037490A1 Targeted modulation of gene expression |
| 03/26/2009 | WO2009037443A1 Transformation of poinsettia plants |
| 03/26/2009 | WO2009037439A2 Methods of switching the phenotype of t cells by transgenic lineage factor foxp3 |
| 03/26/2009 | WO2009037402A2 Hpiv-2 variants and medical applications thereof |
| 03/26/2009 | WO2009037369A1 MANIPULATION OF THE FUNCTION OF AtDBP1 IN ORDER TO GENERATE POTYVIRUS RESISTANCE |
| 03/26/2009 | WO2009037338A1 Plants having increased yield-related traits and a method for making the same |
| 03/26/2009 | WO2009037329A2 Plants with increased yield |
| 03/26/2009 | WO2009037279A1 Plants with increased yield |
| 03/26/2009 | WO2009037258A1 Improved-performance proteases and detergents and cleaning agents comprising said proteases |
| 03/26/2009 | WO2009037253A2 Polypeptides having tyrosinase activity and polynucleotides encoding same |
| 03/26/2009 | WO2009037183A2 Cosmetic and/or pharmaceutical preparation containing nucleic acid for the induction of antimicrobial peptides in epithelia |
| 03/26/2009 | WO2009036997A1 Truncated secretory aspartyl proteinase 2 |
| 03/26/2009 | WO2009036971A1 Means and methods for shrna mediated conditional knockdown of genes |
| 03/26/2009 | WO2009036949A1 Hypoallergenic variants of the major allergen from betula verrucosa pollen |
| 03/26/2009 | WO2009036933A2 Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles |
| 03/26/2009 | WO2009036574A1 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening |
| 03/26/2009 | WO2009021150A3 Platelet derived growth factor receptor supports cytomegalovirus infectivity |
| 03/26/2009 | WO2009016232A3 Plants having enhanced yield-related traits and a method for making the same |
| 03/26/2009 | WO2009013225A3 Plants having enhanced yield-related traits and a method for making the same |
| 03/26/2009 | WO2009010874A3 Preprocalcitonin antigen t epitopes |
| 03/26/2009 | WO2009009142A3 Transgenic plants with enhanced agronomic traits |
| 03/26/2009 | WO2008157729A3 Methods for predicting three-dimensional structures for alpha helical membrane proteins and their use in design of selective ligands |
| 03/26/2009 | WO2008151319A3 Expression of soluble antibody fragment by truncation of ch1 domain |
| 03/26/2009 | WO2008147496A3 Neuraminidase-deficient live influenza vaccines |
| 03/26/2009 | WO2008135467A3 Enhancement of seed oil / amino acid content by combinations of pyruvate kinase subunits |
| 03/26/2009 | WO2008112988A3 Apcdd1 inhibitors for treating, diagnosing or detecting cancer |
| 03/26/2009 | WO2008112008A3 Sensor proteins and assay methods |
| 03/26/2009 | WO2008109490A4 Nucleic acid compounds for inhibiting chek1 gene expression and uses thereof |
| 03/26/2009 | WO2008109378A4 Nucleic acid compounds for inhibiting pdgfr gene expression and uses thereof |
| 03/26/2009 | WO2008098569A3 Biologically active molecules, particularly based on pna and sirna, method for the cell-specific activation thereof, and application kit to be administered |
| 03/26/2009 | WO2008080014A3 Antifungal plant proteins and methods of their use |
| 03/26/2009 | WO2008058996A3 Method for the production of magnetic silicic acid particles |